Alternative nuclear functions for NF-κB family members.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

17 citing papers in PubMed.

1. Transcriptional Regulation during Aberrant Activation of NF-κB Signalling in Cancer.Cells · 2023
   Review
2. Challenges with Methods for Detecting and Studying the Transcription Factor Nuclear Factor Kappa B (NF-κB) in the Central Nervous System.Cells · 2021
   Review
3. Post-translational Modifications of IκBα: The State of the Art.Frontiers in cell and developmental biology · 2020
   Review
4. Manipulation of Non-canonical NF-κB Signaling by Non-oncogenic Viruses.Archivum immunologiae et therapiae experimentalis · 2019
   Review
5. TLR4/NF-κB axis signaling pathway-dependent up-regulation of miR-625-5p contributes to human intervertebral disc degeneration by targetingAmerican journal of translational research · 2019
   Article
6. NF-κB Signaling in Targeting Tumor Cells by Oncolytic Viruses-Therapeutic Perspectives.Cancers · 2018
   Review
7. NF-κB-Mediated Inflammation in the Pathogenesis of Intracranial Aneurysm and Subarachnoid Hemorrhage. Does Autophagy Play a Role?International journal of molecular sciences · 2018
   Review
8. Screening for the Key lncRNA Targets Associated With Metastasis of Renal Clear Cell Carcinoma.Medicine · 2016
   Article
9. Proteasome inhibition increases recruitment of IκB kinase β (IKKβ), S536P-p65, and transcription factor EGR1 to interleukin-8 (IL-8) promoter, resulting in increased IL-8 production in ovarian cancer cells.The Journal of biological chemistry · 2014
   Article
10. The truncate mutation of Notch2 enhances cell proliferation through activating the NF-κB signal pathway in the diffuse large B-cell lymphomas.PloS one · 2014
    Article
11. Proteasome inhibition by bortezomib increases IL-8 expression in androgen-independent prostate cancer cells: the role of IKKα.Journal of immunology (Baltimore, Md. : 1950) · 2013
    Article
12. Chromatin-bound IκBα regulates a subset of polycomb target genes in differentiation and cancer.Cancer cell · 2013
    Article
13. Expression and significance of HMGB1, TLR4 and NF-κB p65 in human epidermal tumors.BMC cancer · 2013
    Article
14. Ubiquitination and the Ubiquitin-Proteasome System as regulators of transcription and transcription factors in epithelial mesenchymal transition of cancer.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2012
    Review
15. Regulation and function of nuclear IκBα in inflammation and cancer.American journal of clinical and experimental immunology · 2012
    Article
16. Depletion of c-Rel from cytokine gene promoters is required for chromatin reassembly and termination of gene responses to T cell activation.PloS one · 2012
    Article
17. The complex interplay between autophagy and NF-κB signaling pathways in cancer cells.American journal of cancer research · 2011
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

3 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

Indexed as